Ethan Liebermann Named to GrowthCap’s Top Healthcare Investors of 2026 List
BOSTON, MA – TA, a leading global private equity firm, is proud to announce that Ethan Liebermann, Managing Director and Head of the Firm’s North America Healthcare Group, has been named to GrowthCap’s “Top Healthcare Investors” list for 2026.
Each year, GrowthCap evaluates hundreds of nominations across the healthcare investing landscape. Awardees are selected based on the depth of their investing experience, professional achievements and feedback from portfolio company executives and industry peers on their impact and leadership.
Ethan’s recognition reflects his meaningful contributions to TA and commitment to supporting the growth and success of our portfolio companies. We congratulate him on this well-deserved honor and value his continued leadership at TA.
To view the full list of honorees and learn more about the selection criteria and methodology, please visit GrowthCap’s website.
About TA
TA is a leading global private equity firm focused on scaling growth in profitable companies. Since 1968, TA has invested in more than 560 companies across its core sectors, including technology, business services, financial services, and healthcare. Leveraging its deep industry expertise and strategic resources, TA collaborates with management teams worldwide to help high-quality companies deliver lasting value. The firm has raised $65 billion in capital to date and has more than 160 investment professionals across offices in Boston, Menlo Park, Austin, London, Mumbai, and Hong Kong. Learn more at www.ta.com.
This award is the opinion of the party conferring the award and not of TA. The Top Healthcare Investors of 2026, issued by GrowthCap on March 25, 2026, was based on the time period of August 20, 2024 to February 20, 2026. TA submitted a nomination, and once selected, paid a publishing and copyright fee to promote this award. There can be no assurance that other providers or surveys would reach the same conclusion as the foregoing.